Pongasi, Janne Boy A.
HRN: 29-99-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/03/2024
10/10/2024
IV
500mg
1 Hour PTOR
Fistula-in-ano
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes